 | • レポートコード：QYR2104Z3938 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：New Technology |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、mRNAワクチンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（開発中、前臨床、臨床I、臨床II）、用途別市場規模（新型コロナウイルス感染症、がん、感染症治療MRNAワクチン、感染予防MRNAワクチン）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・mRNAワクチンの市場動向 ・企業の競争状況、市場シェア ・mRNAワクチンの種類別市場規模（開発中、前臨床、臨床I、臨床II） ・mRNAワクチンの用途別市場規模（新型コロナウイルス感染症、がん、感染症治療MRNAワクチン、感染予防MRNAワクチン） ・mRNAワクチンの北米市場規模2016-2027（アメリカ、カナダ） ・mRNAワクチンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・mRNAワクチンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・mRNAワクチンの中南米市場規模2016-2027（メキシコ、ブラジル） ・mRNAワクチンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（MODERNA、Pfizer、Zydus Cadila、Fosun Pharmaceutical、CureVac、Stemirna） ・結論 |
When the mRNA encoding the antigenic protein is injected into the human body, the antigenic protein can be synthesized in the body, thus causing the human immune response against the pathogen infection, namely the mRNA vaccine.
In 2021, the global mRNA Vaccines market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global mRNA Vaccines status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the mRNA Vaccines development in North America, Europe, Japan, China, Southeast Asia, India, etc.
Global mRNA Vaccines Scope and Market Size
mRNA Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global mRNA Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Being Developed
Preclinical
Clinical I
Clinical II
Segment by Application
COVID-19
Cancer
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
By Region
North America
Europe
Japan
China
Southeast Asia
India
By Company
MODERNA
Pfizer
Zydus Cadila
Fosun Pharmaceutical
CureVac
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Vaccines Market Size Growth Rate by Type (2021-2027)
1.2.2 Being Developed
1.2.3 Preclinical
1.2.4 Clinical I
1.2.5 Clinical II
1.3 Market by Application
1.3.1 Global mRNA Vaccines Market Share by Application (2021-2027)
1.3.2 COVID-19
1.3.3 Cancer
1.3.4 Infectious Disease Treatment MRNA Vaccine
1.3.5 Infection Prevention MRNA Vaccine
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global mRNA Vaccines Market Size
2.2 mRNA Vaccines Market Size by Regions
2.2.1 mRNA Vaccines Growth Rate by Regions (2021-2027)
2.2.2 mRNA Vaccines Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 mRNA Vaccines Revenue by Players (2020-2021)
3.2 mRNA Vaccines Key Players Headquaters and Area Served
3.3 Key Players mRNA Vaccines Product/Solution/Service
3.4 Date of Enter into mRNA Vaccines Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global mRNA Vaccines Market Size by Type (2021-2027)
4.2 Global mRNA Vaccines Market Size by Application (2021-2027)
5 North America
5.1 North America mRNA Vaccines Market Forecast (2021-2027)
5.2 mRNA Vaccines Key Players in North America
5.3 North America mRNA Vaccines Market Size by Type
5.4 North America mRNA Vaccines Market Size by Application
6 Europe
6.1 Europe mRNA Vaccines Market Forecast (2021-2027)
6.2 mRNA Vaccines Key Players in Europe
6.3 Europe mRNA Vaccines Market Size by Type
6.4 Europe mRNA Vaccines Market Size by Application
7 Japan
7.1 Japan mRNA Vaccines Market Forecast (2021-2027)
7.2 mRNA Vaccines Key Players in Europe
7.3 Japan mRNA Vaccines Market Size by Type
7.4 Japan mRNA Vaccines Market Size by Application
8 Rest of World
8.1 China
8.1.1 China mRNA Vaccines Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia mRNA Vaccines Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India mRNA Vaccines Market Analysis
8.3.2 Key Players in India
9 International Player Profiles
9.1 MODERNA
9.1.1 MODERNA Company Details
9.1.2 MODERNA Description and Business Overview
9.1.3 MODERNA mRNA Vaccines Introduction
9.1.4 MODERNA Revenue in mRNA Vaccines Business (2020-2021)
9.1.5 MODERNA Recent Development
9.2 Pfizer
9.2.1 Pfizer Company Details
9.2.2 Pfizer Description and Business Overview
9.2.3 Pfizer mRNA Vaccines Introduction
9.2.4 Pfizer Revenue in mRNA Vaccines Business (2020-2021)
9.2.5 Pfizer Recent Development
9.3 Zydus Cadila
9.3.1 Zydus Cadila Company Details
9.3.2 Zydus Cadila Description and Business Overview
9.3.3 Zydus Cadila mRNA Vaccines Introduction
9.3.4 Zydus Cadila Revenue in mRNA Vaccines Business (2020-2021)
9.3.5 Zydus Cadila Recent Development
9.4 Fosun Pharmaceutical
9.4.1 Fosun Pharmaceutical Company Details
9.4.2 Fosun Pharmaceutical Description and Business Overview
9.4.3 Fosun Pharmaceutical mRNA Vaccines Introduction
9.4.4 Fosun Pharmaceutical Revenue in mRNA Vaccines Business (2020-2021)
9.4.5 Fosun Pharmaceutical Recent Development
9.5 CureVac
9.5.1 CureVac Company Details
9.5.2 CureVac Description and Business Overview
9.5.3 CureVac mRNA Vaccines Introduction
9.5.4 CureVac Revenue in mRNA Vaccines Business (2020-2021)
9.5.5 CureVac Recent Development
9.6 Stemirna
9.6.1 Stemirna Company Details
9.6.2 Stemirna Description and Business Overview
9.6.3 Stemirna mRNA Vaccines Introduction
9.6.4 Stemirna Revenue in mRNA Vaccines Business (2020-2021)
9.6.5 Stemirna Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
Table 1. Global mRNA Vaccines Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of Being Developed
Table 3. Key Players of Preclinical
Table 4. Key Players of Clinical I
Table 5. Key Players of Clinical II
Table 6. Global mRNA Vaccines Market Size Growth by Application (2021-2027) (US$ Million)
Table 7. Global mRNA Vaccines Market Size by Regions (2021-2027) (US$ Million)
Table 8. Global mRNA Vaccines Market Share by Regions (2021-2027)
Table 9. Market Top Trends
Table 10. Market Use Cases
Table 11. Global mRNA Vaccines Revenue by Players (2020-2021) (US$ Million)
Table 12. Global mRNA Vaccines Market Share by Players (2020-2021)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players mRNA Vaccines Product Solution and Service
Table 15. Date of Enter into mRNA Vaccines Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global mRNA Vaccines Market Size by Type (2021-2027) (US$ Million)
Table 18. Global mRNA Vaccines Market Size Share by Type (2021-2027)
Table 19. Global mRNA Vaccines Market Size by Application (2021-2027) (US$ Million)
Table 20. Global mRNA Vaccines Market Size Share by Application (2021-2027)
Table 21. North America Key Players mRNA Vaccines Revenue (2020-2021) (US$ Million)
Table 22. North America Key Players mRNA Vaccines Market Share (2020-2021)
Table 23. North America mRNA Vaccines Market Size by Type (2021-2027) (US$ Million)
Table 24. North America mRNA Vaccines Market Share by Type (2021-2027)
Table 25. North America mRNA Vaccines Market Size by Application (2021-2027) (US$ Million)
Table 26. North America mRNA Vaccines Market Share by Application (2021-2027)
Table 27. Europe Key Players mRNA Vaccines Revenue (2020-2021) (US$ Million)
Table 28. Europe Key Players mRNA Vaccines Market Share (2020-2021)
Table 29. Europe mRNA Vaccines Market Size by Type (2021-2027) (US$ Million)
Table 30. Europe mRNA Vaccines Market Share by Type (2021-2027)
Table 31. Europe mRNA Vaccines Market Size by Application (2021-2027) (US$ Million)
Table 32. Europe mRNA Vaccines Market Share by Application (2021-2027)
Table 33. Japan Key Players mRNA Vaccines Revenue (2020-2021) (US$ Million)
Table 34. Japan Key Players mRNA Vaccines Market Share (2020-2021)
Table 35. Japan mRNA Vaccines Market Size by Type (2021-2027) (US$ Million)
Table 36. Japan mRNA Vaccines Market Share by Type (2021-2027)
Table 37. Japan mRNA Vaccines Market Size by Application (2021-2027) (US$ Million)
Table 38. Japan mRNA Vaccines Market Share by Application (2021-2027)
Table 39. Key Players in China
Table 40. Key Players in Southeast Asia
Table 41. Key Players in India
Table 42. MODERNA Company Details
Table 43. MODERNA Description and Business Overview
Table 44. MODERNA mRNA Vaccines Product
Table 45. MODERNA Revenue in mRNA Vaccines Business 2020 and 2021
Table 46. MODERNA Recent Development
Table 47. Pfizer Company Details
Table 48. Pfizer Description and Business Overview
Table 49. Pfizer mRNA Vaccines Product
Table 50. Pfizer Revenue in mRNA Vaccines Business 2020 and 2021
Table 51. Pfizer Recent Development
Table 52. Zydus Cadila Company Details
Table 53. Zydus Cadila Description and Business Overview
Table 54. Zydus Cadila mRNA Vaccines Product
Table 55. Zydus Cadila Revenue in mRNA Vaccines Business 2020 and 2021
Table 56. Zydus Cadila Recent Development
Table 57. Fosun Pharmaceutical Company Details
Table 58. Fosun Pharmaceutical Description and Business Overview
Table 59. Fosun Pharmaceutical mRNA Vaccines Product
Table 60. Fosun Pharmaceutical Revenue in mRNA Vaccines Business 2020 and 2021
Table 61. Fosun Pharmaceutical Recent Development
Table 62. CureVac Company Details
Table 63. CureVac Description and Business Overview
Table 64. CureVac mRNA Vaccines Product
Table 65. CureVac Revenue in mRNA Vaccines Business 2020 and 2021
Table 66. CureVac Recent Development
Table 67. Stemirna Company Details
Table 68. Stemirna Description and Business Overview
Table 69. Stemirna mRNA Vaccines Product
Table 70. Stemirna Revenue in mRNA Vaccines Business 2020 and 2021
Table 71. Stemirna Recent Development
Table 72. mRNA Vaccines Market Trends
Table 73. mRNA Vaccines Market Drivers
Table 74. mRNA Vaccines Market Challenges
Table 75. mRNA Vaccines Market Restraints
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Vaccines Market Share by Type in 2021 & 2027
Figure 2. Being Developed Features
Figure 3. Preclinical Features
Figure 4. Clinical I Features
Figure 5. Clinical II Features
Figure 6. Global mRNA Vaccines Market Share by Application in 2021 & 2027
Figure 7. COVID-19 Case Studies
Figure 8. Cancer Case Studies
Figure 9. Infectious Disease Treatment MRNA Vaccine Case Studies
Figure 10. Infection Prevention MRNA Vaccine Case Studies
Figure 11. mRNA Vaccines Report Years Considered
Figure 12. Global mRNA Vaccines Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 13. Global mRNA Vaccines Market Share by Regions (2020-2027)
Figure 14. Global mRNA Vaccines Market Share by Players in 2021
Figure 15. Global mRNA Vaccines Market Size Market Share by Type (2021-2027)
Figure 16. Global mRNA Vaccines Market Size Market Share by Application (2021-2027)
Figure 17. Global mRNA Vaccines Revenue Market Share by Application in 2021
Figure 18. North America mRNA Vaccines Market Size 2021-2027 (US$ Million)
Figure 19. Europe mRNA Vaccines Market Size 2021-2027 (US$ Million)
Figure 20. Japan mRNA Vaccines Market Size 2021-2027 (US$ Million)
Figure 21. mRNA Vaccines Market Size in China (2021-2027) (US$ Million)
Figure 22. mRNA Vaccines Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 23. mRNA Vaccines Market Size in India (2021-2027) (US$ Million)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
世界のmRNAがんワクチン・治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global mRNA Cancer Vaccines and Therapeutics Market The global mRNA Cancer Vaccines and Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and…- 世界のmRNA治療市場規模・現状・予測（2021年-2027年） By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for spec…
- 世界のmRNA治療市場規模・現状・予測（2021年-2027年） By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for spec…
- 世界のmRNA療法市場規模・現状・予測（2021年-2027年） By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for spec…
- 世界の新型コロナウイルス感染症RNAワクチン市場規模・現状・予測（2021年-2027年） RNA vaccines are leading the way in vaccines because they are particularly well suited to rapid development.Although no RNA vaccine has yet been approved, the threat of a pandemic is a great incentive to accelerate its progress.RNA vaccines consist of mrna strands.They are injected into the body, us…